HTT and Huntington disease: This transgenic mouse carries copies of a fragment of exon 1 of the human huntingtin gene containing a Q120 repeat expansion that is sufficient to trigger a progressive behavioral and neurological HD-like phenotype that manifests by 4–6 weeks of age (Mangiarini et al. 1996).